Risk factors associated with adverse drug reactions in hospitalised children: International multicentre study

European Journal of Clinical Pharmacology

Volumn 68, Issue 5, 2012, Pages 801-810

  Rashed, Asia N ^a   Wong, Ian C K ^a,b   Cranswick, Noel ^c   Tomlin, Stephen ^d   Rascher, Wolfgang ^e   Neubert, Antje ^a,e  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

^d EVELINA LONDON CHILDREN S HOSPITAL   (United Kingdom)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

ADRs; Children; Inpatient; Multicentre study; Paediatric; Risk factors

Indexed keywords

ANALGESIC AGENT; ANTIANEMIC AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; BLOOD SUBSTITUTE; CORTICOSTEROID; DIURETIC AGENT; IMMUNOSUPPRESSIVE AGENT; LAXATIVE; MINERAL; VITAMIN;

ADOLESCENT; ADULT; ADVERSE DRUG REACTION; ARTICLE; AUSTRALIA; CHILD; CHILD HOSPITALIZATION; COHORT ANALYSIS; DRUG USE; EUROPE; FEMALE; GERMANY; HIGH RISK POPULATION; HONG KONG; HUMAN; INFANT; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALAYSIA; MALE; MEDICAL RECORD; MORBIDITY; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; UNITED KINGDOM;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ASIA; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; COHORT STUDIES; DRUG TOXICITY; EUROPE; FEMALE; HOSPITALS, GENERAL; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; POLYPHARMACY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864286988     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1183-4     Document Type: Article

References (41)

1. Choonara I, Gill A, Nunn A (1996) Drug toxicity and surveillance in children. Br J Clin Pharmacol 42:407-410 (Pubitemid 26340139)
2. Ghaleb M, Barber N, Franklin B, Wong ICK (2010) The incidence and nature of prescribing and medication administration errors in paediatric inpatients. Arch Dis Child 95:113-118
3. Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ (1999) A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 47:681-688 (Pubitemid 29257667)
4. Thurmann PA (2001) Methods: and systems to detect adverse drug reactions in hospitals. Drug Saf 24:961-968 (Pubitemid 33097096)
5. van den Bemt PM, Egberts AC, Lenderink AW et al (2000) Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 22:62-66 (Pubitemid 30306123)
6. Zoppi M, Braunschweig S, Kuenzi UP, Maibach R, Hoigne R (2000) Incidence of lethal adverse drug reactions in the comprehensive hospital drug monitoring, a 20-year survey, 1974-1993, based on the data of Berne/St. Gallen. Eur J Clin Pharmacol 56:427-430 (Pubitemid 30666071)
7. McKenzie MW, Stewart RB, Weiss CF, Cluff LE (1973) A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm 30:898-903
8. González-Martin G, Caroca CM, Paris E (1998) Adverse drug reactions (ADRs) in hospitalized pediatric patients. A prospective study. Int J Clin Pharmacol Ther 36:530-533 (Pubitemid 28468228)
9. Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M (2001) Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 52:77-83 (Pubitemid 32862772)
10. Aagaard L, Christensen A, Hansen EH (2010) Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol 70:481-491
11. Choonara IA, Harris F (1984) Adverse drug reactions in medical inpatients. Arch Dis Child 59:578-580 (Pubitemid 14122095)
12. Rashed A, Wong ICK, Cranswick N, Hefele B, Tomlin S, Jackman J, et al. (2011) Adverse Drug Reactions in Children - International Surveillance and Evaluation (ADVISE): a multicentre cohort study. Drug Saf (in press)
13. WHO (1972) Technical report no. 498. http://who-umc.org/graphics/24756. pdf. Accessed in December 2011
14. WHO (2011) Anatomical Therapeutic Chemical classification. http://www.whocc.no/atc-ddd-index/. Accessed in July 2011
15. WHO (2007) International Classification of Diseases, version 10. http://apps.who.int/classifications/apps/icd/icd10online/. Accessed in December 2011
16. WHO (2003) WHO Adverse Reaction Terminology. http://www.umc-products.com/ graphics/3036.pdf. Accessed in July 2011
17. Schumock GT, Thornton JP (1992) Focusing on the preventability of adverse drug reactions. Hosp Pharm 27:538
18. Dormann H, Muth-Selbach U, Kerbs S et al (2000) Incidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reporting. Drug Saf 22:161-168 (Pubitemid 30072060)
19. EMA (1995) ICH topic E 2 A. Clinical safety data management: definitions and standards for expedited reporting. CPMP/ICH/377/95. http://www.ema.europa. eu/docs/en-GB/document-library/Scientific-guideline/2009/09/WC500002749.pdf. Accessed in December 2011.
20. Pirmohamed M, James S, Meakin S et al (2004) Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 329:15-19 (Pubitemid 38869995)
21. Thuermann PA, Windecker R, Steffen J et al (2002) Detection of adverse drug reactions in a neurological department: comparison between intensified surveillance and a computer-assisted approach. Drug Saf 25:713-724 (Pubitemid 34983374)
22. van der Hooft CS, Dieleman JP, Siemes C et al (2008) Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf 17:365-371 (Pubitemid 351566352)
23. Temple ME, Robinson RF, Miller JC, Hayes JR, Nahata MC (2004) Frequency and preventability of adverse drug reactions in paediatric patients. Drug Saf 27:819-829 (Pubitemid 39243563)
24. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M (2009) Adverse drug reactions in hospital inpatients: a prospective analysis of 3695 patient-episodes. PLoS One 4:e4439
25. Weiss J, Krebs S, Hoffmann C et al (2002) Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 110:254-257 (Pubitemid 34833007)
26. Fattinger K, Roos M, Vergères P et al (2000) Epidemiology of drug exposure and adverse drug reactions in two Swiss departments of internal medicine. Br J Clin Pharmacol 49:158-167 (Pubitemid 30068294)
27. Sánchez Muñoz-Torrero JF et al (2010) Adverse drug reactions in internal medicine units and associated risk factors. Eur J Clin Pharmacol 66:1257-1264
28. Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H (2008) Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf 31:789-798
29. Knopf H, Du Y (2010) Perceived adverse drug reactions among non-institutionalized children and adolescents in Germany. Br J Clin Pharmacol 70:409-417
30. Mitchell AA, Goldman P, Shapiro S, Slone D (1979) Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 110:196-204 (Pubitemid 10209703)
31. Kearns GL, Abdel-Rahman DM, Alander SW, Blowey DL, Leeder JS, Kauffman RE (2003) Developmental pharmacology - drug disposition, action, and therapy in infants and children. N Engl J Med 349:1157-1167 (Pubitemid 37122329)
32. Bates DW, Miller EB, Cullen DJ et al (1999) Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 159:2553-2560
33. Star K, Norén GN, Nordin K, Edwards IR (2011) Suspected adverse drug reaction reported for children worldwide: an exploratory study using VigiBase. Drug Saf 34:415-428
34. Zopf Z, Rabe C, Neubert A et al (2008) Women encounter ADRs more often than do men. Eur J Clin Pharmacol 64:999-1004
35. Caamaño F, Pedone C, Zuccalà G, Carbonin P (2005) Sociodemographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. Arch Gerontol Geriatr 40:45-52 (Pubitemid 39505211)
36. Major S, Badr S, Bahlawan L et al (1998) Drug-related hospitalization at a tertiary teaching centre in Lebanon: incidence, associations, and relation to self-medicating behavior. Clin Pharmacol Ther 64:450-461 (Pubitemid 28473771)
37. Turner S, Nunn AJ, Fielding K, Choonara I (1999) Adverse drug reactions to unlicensed and off-label drugs on paediatric wards: a prospective study. Acta Paediatr 88:965-968 (Pubitemid 29448261)
38. Neubert A, Dormann H, Weiss J et al (2006) Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 62:959-965 (Pubitemid 44657631)
39. Gill AM, Leach HJ, Hughes J, Barker C, Nunn AJ, Choonara I (1995) Adverse drug reactions in a paediatric intensive care unit. Acta Paediatr 84:438-441
40. Sturkenboom MC, Verhamme KMC, Nicolosi A et al (2008) Drug use in children: cohort study in three European countries. BMJ 337:a2245
41. Bennett PN, Brown NJ (2003) Clinical pharmacology. 9th edition. Churchill Livingstone, Edinburgh